Abilify (aripiprazole)

pCPA File Number: 20793

Negotiation Status:

Concluded without agreement

Indication(s):

Schizophrenia and Related Psychotic Disorders

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2016-06-01

Negotiation Process Concluded:

2017-03-31